Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies

Project Information

INFLA-CARE

Grant agreement ID: 223151

Project closed

Start date 1 January 2009

End date 30 June 2013

Funded under

• Specific Programme "Cooperation": Health

Total cost € 16 211 687,27

EU contribution € 11 999 889,00

Coordinated by

IDRYMA TECHNOLOGIAS KAI EREVNAS
Greece